Gyre Therapeutics director Kirkby Maxwell files initial beneficial ownership statement
GYRE•Form 3 filing by director
Gyre Therapeutics director Maxwell Kirkby filed an initial Form 3 beneficial ownership statement dated Aug. 1, 2026.
Related News
DigitalOcean forecast beats Wall Street estimates on AI boom strength
DOCN•
Trump advisers tell AI firms they will not safety-test open-weight models
QQQ•
Gilead <GILD.O>: Truist Securities cuts target price to $150 from $156
GILD•
SpaceX's mobile ambitions jolt US telecom market, analysts debate threat
XLC•
Grace Therapeutics prices USD 10 million private placement at USD 2.1 per share
GRCE•